NR4A1 and stress-related disorder: However, evidence exists that other antidepressants, such as vortioxetine [14] and fluoxetine [36], increased the expression of this gene, further supporting the notion that Nr4a1 may represent a target for the development of novel drugs to treat stress-related disorders.